Cargando…

Validation of extracellular ligand–receptor interactions by Flow-TriCEPS

OBJECTIVE: The advent of ligand-based receptor capture methodologies, allows the identification of unknown receptor candidates for orphan extracellular ligands. However, further target validation can be tedious, laborious and time-consuming. Here, we present a methodology that provides a fast and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Garcia, Laura A., Demiray, Levent, Ruch-Marder, Sandra, Hopp, Ann-Katrin, Hottiger, Michael O., Helbling, Paul M., Pavlou, Maria P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280402/
https://www.ncbi.nlm.nih.gov/pubmed/30518414
http://dx.doi.org/10.1186/s13104-018-3974-5
_version_ 1783378662673874944
author Lopez-Garcia, Laura A.
Demiray, Levent
Ruch-Marder, Sandra
Hopp, Ann-Katrin
Hottiger, Michael O.
Helbling, Paul M.
Pavlou, Maria P.
author_facet Lopez-Garcia, Laura A.
Demiray, Levent
Ruch-Marder, Sandra
Hopp, Ann-Katrin
Hottiger, Michael O.
Helbling, Paul M.
Pavlou, Maria P.
author_sort Lopez-Garcia, Laura A.
collection PubMed
description OBJECTIVE: The advent of ligand-based receptor capture methodologies, allows the identification of unknown receptor candidates for orphan extracellular ligands. However, further target validation can be tedious, laborious and time-consuming. Here, we present a methodology that provides a fast and cost-efficient alternative for candidate target verification on living cells. RESULTS: In the described methodology a ligand of interest (e.g. transferrin, epidermal growth factor or insulin) was conjugated to a linker (TriCEPS) that carries a biotin. To confirm ligand/receptor interactions, the ligand–TriCEPS conjugates were first added onto living cells and cells were subsequently labeled with a streptavidin-fluorophore and analyzed by flow cytometry (thus referred as Flow-TriCEPS). Flow-TriCEPS was also used to validate identified receptor candidates when combined with a siRNA knock down approach (i.e. reduction of expression levels). This approach is versatile as it can be applied for different classes of ligands (proteins, peptides, antibodies) and different cell lines. Moreover, the method is time-efficient since it takes advantage of the large variety of commercially available (and certified) siRNAs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-018-3974-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6280402
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62804022018-12-10 Validation of extracellular ligand–receptor interactions by Flow-TriCEPS Lopez-Garcia, Laura A. Demiray, Levent Ruch-Marder, Sandra Hopp, Ann-Katrin Hottiger, Michael O. Helbling, Paul M. Pavlou, Maria P. BMC Res Notes Research Note OBJECTIVE: The advent of ligand-based receptor capture methodologies, allows the identification of unknown receptor candidates for orphan extracellular ligands. However, further target validation can be tedious, laborious and time-consuming. Here, we present a methodology that provides a fast and cost-efficient alternative for candidate target verification on living cells. RESULTS: In the described methodology a ligand of interest (e.g. transferrin, epidermal growth factor or insulin) was conjugated to a linker (TriCEPS) that carries a biotin. To confirm ligand/receptor interactions, the ligand–TriCEPS conjugates were first added onto living cells and cells were subsequently labeled with a streptavidin-fluorophore and analyzed by flow cytometry (thus referred as Flow-TriCEPS). Flow-TriCEPS was also used to validate identified receptor candidates when combined with a siRNA knock down approach (i.e. reduction of expression levels). This approach is versatile as it can be applied for different classes of ligands (proteins, peptides, antibodies) and different cell lines. Moreover, the method is time-efficient since it takes advantage of the large variety of commercially available (and certified) siRNAs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-018-3974-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-05 /pmc/articles/PMC6280402/ /pubmed/30518414 http://dx.doi.org/10.1186/s13104-018-3974-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Lopez-Garcia, Laura A.
Demiray, Levent
Ruch-Marder, Sandra
Hopp, Ann-Katrin
Hottiger, Michael O.
Helbling, Paul M.
Pavlou, Maria P.
Validation of extracellular ligand–receptor interactions by Flow-TriCEPS
title Validation of extracellular ligand–receptor interactions by Flow-TriCEPS
title_full Validation of extracellular ligand–receptor interactions by Flow-TriCEPS
title_fullStr Validation of extracellular ligand–receptor interactions by Flow-TriCEPS
title_full_unstemmed Validation of extracellular ligand–receptor interactions by Flow-TriCEPS
title_short Validation of extracellular ligand–receptor interactions by Flow-TriCEPS
title_sort validation of extracellular ligand–receptor interactions by flow-triceps
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280402/
https://www.ncbi.nlm.nih.gov/pubmed/30518414
http://dx.doi.org/10.1186/s13104-018-3974-5
work_keys_str_mv AT lopezgarcialauraa validationofextracellularligandreceptorinteractionsbyflowtriceps
AT demiraylevent validationofextracellularligandreceptorinteractionsbyflowtriceps
AT ruchmardersandra validationofextracellularligandreceptorinteractionsbyflowtriceps
AT hoppannkatrin validationofextracellularligandreceptorinteractionsbyflowtriceps
AT hottigermichaelo validationofextracellularligandreceptorinteractionsbyflowtriceps
AT helblingpaulm validationofextracellularligandreceptorinteractionsbyflowtriceps
AT pavloumariap validationofextracellularligandreceptorinteractionsbyflowtriceps